Literature DB >> 2293641

Elevation of salivary antimicrobial proteins following HIV-1 infection.

J C Atkinson1, C Yeh, F G Oppenheim, D Bermudez, B J Baum, P C Fox.   

Abstract

Thirty-seven HIV-1-positive patients contributed salivary samples from individual major salivary glands. Nineteen patients were unmedicated and asymptomatic, and 18 patients had developed signs of AIDS. Salivas from 15 healthy males served as controls. Levels of four salivary antimicrobial proteins (lactoferrin, lysozyme, secretory IgA, and histatins) were determined, as well as total fluid output of the major salivary glands. Concentrations of all four salivary antimicrobial proteins were found to be increased in the stimulated submandibular/sublingual saliva of all HIV-1-positive patients as well as the subset of unmediated HIV-1-positive patients. Those patients with evidence of oral candidiasis had the highest concentrations of lysozyme and histatins, potent antifungal proteins, in their saliva. Although the etiology of these protein increases is still unknown, these results further document salivary changes following HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293641

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  14 in total

1.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Increases in salivary lysozyme and IgA concentrations and secretory rates independent of salivary flow rates following viewing of humorous videotape.

Authors:  S Perera; E Sabin; P Nelson; D Lowe
Journal:  Int J Behav Med       Date:  1998

Review 3.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

4.  Salivary IgA versus HIV and Dental Caries.

Authors:  Pradip Kumar Mandal; Malay Mitra; Sonu Acharya; Chiranjit Ghosh; Susant Mohanty; Subrata Saha
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 5.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

6.  Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays.

Authors:  A L Lin; Q Shi; D A Johnson; T F Patterson; M G Rinaldi; C K Yeh
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 8.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection.

Authors:  L E Soto-Ramírez; L Hernández-Gómez; J Sifuentes-Osornio; G Barriga-Angulo; D Duarte de Lima; M López-Portillo; G M Ruiz-Palacios
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Anticandidal activity of major human salivary histatins.

Authors:  T Xu; S M Levitz; R D Diamond; F G Oppenheim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.